Author:
Klager Skylar,Khalil Marina,Shulman Kenneth,Sami Naveed
Reference10 articles.
1. Fixed drug eruption to biologics and role of lesional patch testing;Li;J Allergy Clin Immunol Pract,2019
2. A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine;Camporeale;BMC Neurol,2018
3. Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial;Skljarevski;Cephalalgia,2018
4. Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study;Detke;Neurology,2018
5. Immunogenicity of protein therapeutics: the key causes, consequences and challenges;Baker;Self Nonself,2010
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献